{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:14:27Z","timestamp":1790190867568,"version":"4.1.0"},"reference-count":35,"publisher":"American Society of Tropical Medicine and Hygiene","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,6]]},"abstract":"<jats:p>Rocky Mountain spotted fever (RMSF), caused by <jats:italic>Rickettsia rickettsii<\/jats:italic>, is a severe tick-borne infection endemic to the Americas. Oral doxycycline is effective, but during severe life-threatening disease, intravenous therapy is recommended. Unfortunately, intravenous formulations of doxycycline are not always available. Therefore, we aimed to determine the susceptibility of <jats:italic>R. rickettsii<\/jats:italic> to an alternative parenteral agent, tigecycline, in vitro and in vivo. To determine the minimum inhibitory concentration of tigecycline, <jats:italic>R. rickettsii<\/jats:italic>\u2013inoculated Vero cells were incubated with medium containing tigecycline. At various time points, monolayers were collected and <jats:italic>R. rickettsii<\/jats:italic> was quantified via real-time polymerase chain reaction (PCR). The growth of <jats:italic>R. rickettsii<\/jats:italic> was inhibited in the presence of \u2265 0.5 \u00b5g\/mL of tigecycline. To determine the effectiveness of tigecycline in vivo, guinea pigs were inoculated with <jats:italic>R. rickettsii.<\/jats:italic> Five days after inoculation, they were treated twice daily with subcutaneous tigecycline 3.75 mg\/kg or subcutaneous doxycycline 5 mg\/kg. Treated animals improved, whereas untreated controls remained ill. Tissues were collected for quantitative PCR\u2013determined bacterial loads on day 8. Median bacterial loads in the tigecycline group were less than those in untreated animals: liver (0 versus 2.9 \u00d7 10<jats:sup>4<\/jats:sup> copies\/mg), lung (0 versus 8.3 \u00d7 10<jats:sup>3<\/jats:sup> copies\/mg), skin (2.6 \u00d7 10<jats:sup>2<\/jats:sup> versus 2.2 \u00d7 10<jats:sup>5<\/jats:sup> copies\/mg), spleen (0 versus 1.3 \u00d7 10<jats:sup>4<\/jats:sup> copies\/mg), and testes (0 versus 1.0 \u00d7 10<jats:sup>5<\/jats:sup> copies\/mg, respectively). There were no significant differences in the bacterial loads between doxycycline-treated versus tigecycline-treated guinea pigs. These data indicate that tigecycline is effective against <jats:italic>R. rickettsii<\/jats:italic> in cell culture and in an animal model of RMSF.<\/jats:p>","DOI":"10.4269\/ajtmh.19-0445","type":"journal-article","created":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T07:00:34Z","timestamp":1568358034000},"page":"1091-1095","source":"Crossref","is-referenced-by-count":14,"title":["Susceptibility of Rickettsia rickettsii to Tigecycline in a Cell Culture Assay and Animal Model for Rocky Mountain Spotted Fever"],"prefix":"10.4269","volume":"101","author":[{"given":"Lucas S.","family":"Blanton","sequence":"first","affiliation":[{"name":"Department of Internal Medicine\u2013Infectious Diseases, University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Wilson","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany R.","family":"Quade","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine\u2013Infectious Diseases, University of Texas Medical Branch, Galveston, Texas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Walker","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Texas Medical Branch, Galveston, Texas"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2795","reference":[{"key":"b1","series-title":"Bergey\u2019s Manual of Systematic Bacteriology","first-page":"96","article-title":"Family I. Rickettsiaceae","author":"Yu","year":"2005"},{"key":"b2","series-title":"Clin Microbiol Rev","first-page":"657","article-title":"Update on tick-borne rickettsioses around the world: a geographic approach","volume":"26","author":"Parola","year":"2013"},{"key":"b3","series-title":"Med Clin North Am","first-page":"1345","article-title":"Emerging and re-emerging tick-transmitted rickettsial and ehrlichial infections","volume":"92","author":"Walker","year":"2008"},{"key":"b4","series-title":"Cad Saude Publica","first-page":"1969","article-title":"Epidemiological characteristics of Brazilian spotted fever in Minas Gerais state, Brazil, 2000\u20132008","volume":"27","author":"Amancio","year":"2011"},{"key":"b5","series-title":"MMWR Morb Mortal Wkly Rep","first-page":"1302","article-title":"Notes from the field: community-based prevention of Rocky Mountain spotted fever\u2013Sonora, Mexico, 2016","volume":"65","author":"Straily","year":"2016"},{"key":"b6","series-title":"MMWR Recomm Rep","first-page":"1","article-title":"Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever and other spotted fever group rickettsioses, ehrlichioses, and anaplasmosis\u2013United States","volume":"65","author":"Biggs","year":"2016"},{"key":"b7","series-title":"Can Med Assoc J","first-page":"1031","article-title":"Studies on the absorption and distribution of doxycycline in normal patients and in patients with severely impaired renal function","volume":"103","author":"Mahon","year":"1970"},{"key":"b8","series-title":"Expert Opin Drug Metab Toxicol","first-page":"1067","article-title":"Drug absorption, distribution, metabolism and excretion considerations in critically ill adults","volume":"9","author":"Roberts","year":"2013"},{"key":"b9","series-title":"J Antimicrob Chemother","first-page":"592","article-title":"Comparison of tetracycline and tigecycline binding to ribosomes mapped by dimethylsulphate and drug-directed Fe2+ cleavage of 16S rRNA","volume":"53","author":"Bauer","year":"2004"},{"key":"b10","series-title":"Clin Infect Dis","first-page":"S354","article-title":"The efficacy and safety of tigecycline for the treatment of complicated intra-abdominal infections: analysis of pooled clinical trial data","volume":"41","author":"Babinchak","year":"2005"},{"key":"b11","series-title":"Clin Infect Dis","first-page":"S341","article-title":"The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin\u2013aztreonam","volume":"41","author":"Ellis-Grosse","year":"2005"},{"key":"b12","series-title":"Diagn Microbiol Infect Dis","first-page":"329","article-title":"Integrated results of 2 phase 3 studies comparing tigecycline and levofloxacin in community-acquired pneumonia","volume":"61","author":"Tanaseanu","year":"2008"},{"key":"b13","series-title":"Drugs","first-page":"63","article-title":"The glycylcyclines: a comparative review with the tetracyclines","volume":"64","author":"Zhanel","year":"2004"},{"key":"b14","series-title":"J Clin Microbiol","first-page":"90","article-title":"Rickettsia species infecting Amblyomma cooperi ticks from an area in the state of Sao Paulo, Brazil, where Brazilian spotted fever is endemic","volume":"42","author":"Labruna","year":"2004"},{"key":"b15","series-title":"Antimicrob Agents Chemother","first-page":"533","article-title":"Activities of tigecycline (GAR-936) against Legionella pneumophila in vitro and in guinea pigs with L. pneumophila pneumonia","volume":"47","author":"Edelstein","year":"2003"},{"key":"b16","series-title":"Manual of Clinical Microbiology","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1128\/9781683670438.MCM.ch66","article-title":"Rickettsia and Orientia","author":"Blanton","year":"2019"},{"key":"b17","series-title":"Intracellular Pathogens II: Rickettsiales","first-page":"1","article-title":"Clincial disease: current treatment and new challenges","author":"Dumler","year":"2012"},{"key":"b18","series-title":"Appl Microbiol","first-page":"133","article-title":"Determination of antibiotic susceptibility of Rickettsia by the plaque assay technique","volume":"18","author":"McDade","year":"1969"},{"key":"b19","series-title":"Antimicrob Agents Chemother","first-page":"1537","article-title":"In vitro susceptibilities of 27 rickettsiae to 13 antimicrobials","volume":"42","author":"Rolain","year":"1998"},{"key":"b20","series-title":"Antimicrob Agents Chemother","first-page":"2747","article-title":"Evaluation of antibiotic susceptibilities of three rickettsial species including Rickettsia felis by a quantitative PCR DNA assay","volume":"46","author":"Rolain","year":"2002"},{"key":"b21","series-title":"J Immunol","first-page":"49","article-title":"Chloromycetin in experimental rickettsial infections","volume":"62","author":"Smadel","year":"1949"},{"key":"b22","series-title":"J Antimicrob Chemother","first-page":"725","article-title":"Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, \u2018Israeli spotted fever group rickettsia\u2019 and Coxiella burnetii","volume":"39","author":"Maurin","year":"1997"},{"key":"b23","series-title":"Antimicrob Agents Chemother","first-page":"2457","article-title":"Antimicrobial therapy of rickettsial diseases","volume":"35","author":"Raoult","year":"1991"},{"key":"b24","series-title":"Antimicrob Agents Chemother","first-page":"e01135\u201317","article-title":"Comparison of omadacycline and tigecycline pharmacokinetics in the plasma, epithelial lining fluid, and alveolar cells of healthy adult subjects","volume":"61","author":"Gotfried","year":"2017"},{"key":"b25","series-title":"J Antimicrob Chemother","first-page":"i11","article-title":"Tigecycline pharmacokinetic\/pharmacodynamic update","volume":"62","author":"MacGowan","year":"2008"},{"key":"b26","series-title":"J Infect Dis","first-page":"433","article-title":"Randomized trial of 5-day rifampin versus 1-day doxycycline therapy for Mediterranean spotted fever","volume":"164","author":"Bella","year":"1991"},{"key":"b27","series-title":"Int J Infect Dis","first-page":"10","article-title":"Spotted fever from Rickettsia typhi in an older woman: a case report from a geographic area where it would not be expected","volume":"27","author":"Luciani","year":"2014"},{"key":"b28","series-title":"Ann Intern Med","first-page":"17","article-title":"Endemic (murine) typhus fever: clinical observations of 180 cases","volume":"23","author":"Stuart","year":"1945"},{"key":"b29","series-title":"Rev Panam Salud Publica","first-page":"461","article-title":"Rocky Mountain spotted fever in Brazil","volume":"27","author":"del Sa DelFiol","year":"2010"},{"key":"b30","series-title":"Lancet Infect Dis","first-page":"e189","article-title":"Rocky Mountain spotted fever in Mexico: past, present, and future","volume":"17","author":"Alvarez-Hernandez","year":"2017"},{"key":"b31","series-title":"J Infect Dis","first-page":"1437","article-title":"Analysis of risk factors for fatal Rocky Mountain spotted fever: evidence for superiority of tetracyclines for therapy","volume":"184","author":"Holman","year":"2001"},{"key":"b32","series-title":"JAMA","first-page":"2045","article-title":"Statewide study of chloramphenicol therapy and fatal aplastic anemia","volume":"208","author":"Wallerstein","year":"1969"},{"key":"b33","series-title":"Pediatr Infect Dis J","first-page":"1042","article-title":"Azithromycin vs. doxycycline for Mediterranean spotted fever","volume":"15","author":"Meloni","year":"1996"},{"key":"b34","series-title":"Eur J Clin Microbiol Infect Dis","first-page":"427","article-title":"Evaluation of ciprofloxacin and doxycycline in the treatment of Mediterranean spotted fever","volume":"11","author":"Ruiz Beltran","year":"1992"},{"key":"b35","series-title":"Antimicrob Agents Chemother","first-page":"606","article-title":"Ciprofloxacin therapy for Mediterranean spotted fever","volume":"30","author":"Raoult","year":"1986"}],"container-title":["The American Journal of Tropical Medicine and Hygiene"],"original-title":[],"link":[{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/101\/5\/article-p1091.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/101\/5\/article-p1091.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/www.ajtmh.org\/downloadpdf\/journals\/tpmd\/101\/5\/article-p1091.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T21:38:04Z","timestamp":1722461884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ajtmh.org\/view\/journals\/tpmd\/101\/5\/article-p1091.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,6]]},"references-count":35,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.4269\/ajtmh.19-0445","relation":{},"ISSN":["0002-9637","1476-1645"],"issn-type":[{"value":"0002-9637","type":"print"},{"value":"1476-1645","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,6]]}}}